SNY : Summary for Sanofi American Depositary Shar - Yahoo Finance

U.S. Markets closed

Sanofi (SNY)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
40.17-0.59 (-1.45%)
At close: 4:01PM EST

40.17 0.00 (0.00%)
After hours: 6:21PM EST

People also watch
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Previous Close40.76
Bid0.00 x
Ask0.00 x
Day's Range40.00 - 40.37
52 Week Range36.81 - 44.50
Avg. Volume2,231,429
Market Cap102.83B
PE Ratio (TTM)23.35
Earnings DateN/A
Dividend & Yield1.66 (4.06%)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • MannKind Has a New Plan, but Will It Work?
    Motley Foolyesterday

    MannKind Has a New Plan, but Will It Work?

    MannKind plans to more than double its sales force and air TV commercials plus more to increase Afrezza sales. Will this plan work?

  • Sanofi Diabetes Drug Suliqua Wins EU Marketing Approval
    Zacks2 days ago

    Sanofi Diabetes Drug Suliqua Wins EU Marketing Approval

    Sanofi (SNY) announced that the European Commission has granted marketing authorization to its once-daily injection, Suliqua a combination of diabetes drugs Lantus and lixisenatide for the treatment of diabetes.

  • Reuters2 days ago

    Drugmakers in Davos shift focus to chronic diseases of poor

    Two decades after they were spurred into action to tackle AIDS in Africa, global drugmakers said on Wednesday they would invest an initial $50 million over three years to fight cancer and other non-communicable diseases in poor countries. Twenty-two companies, including Pfizer, Merck , Novartis, Roche, Sanofi and GlaxoSmithKline, will contribute funds and expertise to the project, which is backed by the World Bank. The so-called Access Accelerated initiative was announced at the World Economic Forum in Davos and aims to improve both treatment and prevention.